Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2022.12.28
智信：深圳市智信药业集团股份有限公司关于拟下调“20智信”公司债券票面利率的提示...
2022.12.09
智信：关于延长员工持股计划存续期的公告
2022.12.09
智信：独立董事关于第五届董事会第二十四次会议相关事项的独立意见
2022.12.09
智信：第五届董事会第二十四次会议决议公告
2022.11.08
智信：2022年第二次临时股东大会决议公告
2022.10.14
智信：H股公告
2022.10.01
智信：第五届监事会第十二次会议决议公告
2022.10.01
智信：第五届董事会第二十二次会议决议公告
2022.10.01
智信：独立董事关于第五届董事会第二十二次会议相关事项的独立意见
2022.10.01
智信：关于变更H股募集资金使用用途的公告
第一页
上一页
14
15
16
17
18
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
